Euro
USD
British Pound
NULL
Product Description
Polypeptide N-acetylgalactosaminyltransferase 16 (GalNAc-T16) catalyzes the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the hydroxyl group of serine and threonine residues. Twenty GalNAc-T genes have been identified in humans and most have been shown to represent active GalNAc-Ts. All isoforms are type II transmembrane proteins, with different but partly overlapping substrate preferences. The GalNAc-Ts control the initiation of mucin-type O-linked glycosylation and determine the location and density of O-glycans in a protein. Addition of GalNAc to an unglycosylated Ser/Thr residue creates the Tn antigen GalNAc1-S/T, and subsequent addition of sialic acid by ST6GalNAc-I forms the cancer associated STn antigen.
Biovision | P1218 | GalNAc-T16 soluble fragment Human Recombinant DataSheet
Biomolecule/Target: GALNT16
Synonyms: Polypeptide N-acetylgalactosaminyltransferase, Protein-UDP acetylgalactosaminyltransferase, GALNTL1, GALNT16
Alternates names: Polypeptide N-acetylgalactosaminyltransferase, Protein-UDP acetylgalactosaminyltransferase, GALNTL1, GALNT16
Taglines: Involved in the pathway protein glycosylation
NCBI Gene ID #: 14180
NCBI Gene Symbol: FGF-9
Gene Source: Human
Accession #: P54130
Recombinant: Yes
Source: Insect cells
Purity by SDS-PAGEs: 98%
Assay: SDS-PAGE
Purity: N/A
Assay #2: N/A
Endotoxin Level: N/A
Activity (Specifications/test method): N/A
Biological activity: N/A
Results: N/A
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: N/A
Concentration: 100 ug/ml
Appearance: Liquid
Physical form description: Sterile filtered solution in 25 mM Tris pH 7.5 and 150 mM NaCl
Reconstitution Instructions: N/A
Amino acid sequence: N/A
